All posts by admin

20Jan/14

European Approval for Gilead Drug – Analyst Blog – NASDAQ

Transplantation

Witney Gazette

European Approval for Gilead Drug – Analyst Blog
NASDAQ
The EC cleared the drug as an all-oral therapy for treating patients affected with genotypes 1, 2, 3, 4, 5 or 6 of the virus. Sovaldi in combination with ribavirin can also be used to treat chronic HCV patients awaiting liver transplantation to prevent …
EU clears Gilead’s hepatitis C therapy SovaldiPMLiVE
European Commission grants marketing authorization for Gilead’s SovaldiPharmaceutical Business Review
Gilead Sciences Inc receives marketing authorisation for Sovaldi for treating …MENAFN.COM
expressandstar.com
all 21 news articles »
20Jan/14

The case for a kidney marketplace – PBS NewsHour

Transplant Surgery

PBS NewsHour

The case for a kidney marketplace
PBS NewsHour
Paying kidney donors for their organs may help to close the growing supply gap for transplant surgery in the United States, say two prominent economists. Nobel-prize winning economist Gary Becker and colleague Julio Elias made waves Sunday in an essay …
Response to: “Cash for Kidneys: The Case for a Market for Organs”ScienceBlog.com (blog)
Pressuring Poor People to Sell Their Organs: Economists Push “Cash for Kidneys”LifeNews.com
Cash for Kidneys: The Case for a Market for OrgansWall Street Journal

all 15 news articles »
20Jan/14

Research and Markets: Worldwide Engineered T-Cell Receptor in Fusion … – Business Wire (press release)

Antibodies

Research and Markets: Worldwide Engineered T-Cell Receptor in Fusion …
Business Wire (press release)
This report entitled ‘The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry’ describes chances and pitfalls in exploiting the opportunities which offers the engineered T-cell …